Freeline Therapeutics Holdings plc Recorded Big Gain
Tue, Jul 11, 2023 at 07:44 PM
Freeline Therapeutics Holdings plc (FRLN:NASDAQ) shot up at $3.71, representing a gain of 38.4%. On Tue, Jul 11, 2023, FRLN:NASDAQ hit a New 2-Week High of $3.71. From Tue, Jun 27, 2023, the stock recorded 66.67% Up Days and 80.00% Green Days
About Freeline Therapeutics Holdings plc (FRLN:NASDAQ)
Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from...
Top 10 Gainers:
- PainReform Ltd. (PRFX:NASDAQ), 307.41%
- Adial Pharmaceuticals, Inc. (ADIL:NASDAQ), 90.31%
- CytoMed Therapeutics Limited (GDTC:NASDAQ), 61.6%
- Yellow Corporation (YELL:NASDAQ), 45.15%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 42.22%
- Freeline Therapeutics Holdings plc (FRLN:NASDAQ), 38.43%
- Knightscope Inc. (KSCP:NASDAQ), 36.6%
- Taoping Inc. (TAOP:NASDAQ), 32.58%
- SOS Limited American Depositary Shares (SOS:NYSE), 31.17%
- UTime Limited (UTME:NASDAQ), 28.86%